Business Context and Reporting Period
This Form 8-K was filed by Genprex, Inc. on January 25, 2019. The company is incorporated in Delaware and is classified as an emerging growth company. The report details executive compensation adjustments approved by the Board of Directors on January 25, 2019, effective January 1, 2019.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The Board approved the following changes to executive compensation:
- Base Salary Increases: Effective January 1, 2019, base salaries were increased for the CEO, President/COO, and CFO.
- Target Bonus Opportunities: New performance-based bonus targets were established for 2019, ranging from 40% to 75% of base salary depending on the role.
- Stock Option Grants: Additional stock options were granted under the 2018 Equity Incentive Plan with an exercise price of $1.62 per share.
Executive Compensation Details
| Officer | Title | Base Salary | Target Bonus % | Stock Options Granted |
|---|---|---|---|---|
| Rodney Varner | Chief Executive Officer | $400,000 | 75% | 615,384 |
| Julien Pham | President and COO | $375,000 | 50% | 432,692 |
| Ryan Confer | Chief Financial Officer | $300,000 | 40% | 230,769 |
Outlook, Risks, and Unusual Items
Vesting Schedule: The granted stock options are subject to a three-year vesting schedule, with 1/36 vesting monthly following the grant date, contingent upon continued service.
Performance Objectives: Bonus payments are calculated based on performance objectives mutually agreed upon between the executive officer and the Board. The filing does not disclose the specific metrics used to determine these bonuses.
Risks: The filing does not explicitly list new risks or contingencies beyond the standard conditions of employment and equity vesting.
Investor Verification Checklist
- Verify the specific performance objectives tied to the 2019 target bonus opportunities, as these are not detailed in the filing.
- Confirm the total number of shares available under the 2018 Equity Incentive Plan to assess the impact of these new grants on dilution.
- Review the company's most recent 10-K or 10-Q for current cash position to evaluate the ability to fund the increased base salaries and potential bonus payouts.
- Check subsequent filings for any changes to the vesting schedule or exercise price due to stock splits or other corporate actions.